NovaBridge Biosciences Contract with Customer, Liability, Noncurrent
NovaBridge Biosciences (NBP) had Contract with Customer, Liability, Noncurrent of CNY 292.12 million as of 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2024-04-30
- 2023-12-31: Contract with Customer, Liability, Noncurrent 292.12M CNY.
- 2022-12-31: Contract with Customer, Liability, Noncurrent 267.88M CNY.
- 2022-06-30: Contract with Customer, Liability, Noncurrent 240.01M CNY.
- 2021-12-31: Contract with Customer, Liability, Noncurrent 224.00M CNY.
CNY
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2023-12-31 | 292.12M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 267.88M CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 240.01M CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 224.00M CNY 20-F · filed 2023-05-01 |
USD
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2023-12-31 | $41.15M 20-F · filed 2024-04-30 |
| 2022-12-31 | $38.84M 20-F · filed 2023-05-01 |
| 2022-06-30 | $35.83M 6-K · filed 2022-11-10 |
| 2021-12-31 | $35.15M 20-F · filed 2022-04-29 |